EU approves use of remdesivir to treat covid-19

The use of the drug known as remdesivir has been approved by the European Union to treat the deadly COVID-19 disease which has fast spread across the globe.

This was revealed on Friday by the EU Health Commissioner, Stella Kyriakides who informed that the drug will now be used to treat severe cases of COVID-19.

Stella said; “Today’s authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus.

READ ALSO: US secures three-month stock of key COVID-19 drug, Remdesivir, leaving none for UK, EU

“We are granting this authorisation less than a month after the application was submitted, showing clearly the EU’s determination to respond quickly whenever new treatments become available.”

The approval of the drug came after two major US studies showed that remdesivir can reduce the duration of hospital stay for COVID-19 patients.

The US has however effectively stockpiled almost the world’s entire supply of the antiviral medication.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now